Risks of Untreated Obstructive Sleep Apnea
Untreated obstructive sleep apnea significantly increases your risk of cardiovascular disease, stroke, heart failure, hypertension, diabetes, traffic accidents, and all-cause mortality 1, 2.
Cardiovascular and Cerebrovascular Consequences
The most serious risks of untreated OSA involve your cardiovascular system. Moderate to severe untreated OSA is directly linked to hypertension, cardiac arrhythmias, coronary artery disease, and congestive heart failure 3. The evidence shows that OSA acts as an independent risk factor for these conditions, though the guideline evidence notes that the effect of treatment on reducing cardiovascular events and death remains uncertain 4.
Stroke risk is substantially elevated in untreated OSA patients 5, 2. The repetitive hypoxemia and sleep fragmentation create a pathophysiological environment that promotes vascular damage and thrombotic events.
Metabolic Complications
Untreated OSA increases your risk of developing type 2 diabetes mellitus and metabolic syndrome 2, 6. The chronic intermittent hypoxia and sleep disruption impair glucose metabolism and insulin sensitivity. While the ACP guideline notes insufficient evidence that CPAP treatment improves diabetes outcomes 4, the association between untreated OSA and metabolic disease is well-established.
Neurological and Cognitive Effects
Cognitive impairment, memory decline, and impaired attention are direct consequences of untreated OSA 6. The chronic sleep fragmentation and hypoxemia damage neurological function over time. Depression and anxiety disorders are also commonly observed in untreated patients 6.
Safety Risks
Untreated OSA dramatically increases the risk of traffic and occupational accidents 1, 6. The excessive daytime sleepiness that characterizes OSA impairs reaction time and judgment. This is particularly critical for individuals in high-risk occupations or those who drive regularly.
Quality of Life Impact
Beyond mortality and morbidity, untreated OSA severely degrades quality of life through:
- Excessive daytime sleepiness that interferes with work and daily activities 4, 6
- Non-restorative sleep leading to chronic fatigue 6
- Reduced sexual function 6
- Morning headaches and dry mouth 6
- Nocturia disrupting sleep further 6
Additional Complications
The evidence also suggests associations between untreated OSA and:
- Increased malignancy risk 6
- Chronic cough and asthma exacerbation 6
- COPD progression 6
- Dental complications including bruxism and xerostomia 7
Critical Caveat
The ACP guideline acknowledges that while CPAP improves daytime sleepiness and sleep parameters, evidence remains insufficient to prove it reduces cardiovascular events or mortality 4. This creates a paradox: we know untreated OSA causes these complications, but treatment trials have not definitively proven risk reduction—likely due to poor CPAP adherence in studies 3.
High-Risk Populations Requiring Immediate Attention
Screening and treatment should be prioritized for 6:
- Middle-aged and older men
- Obese individuals (especially BMI >30)
- Patients with existing hypertension, cardiovascular disease, or diabetes
- Perioperative patients (particularly bariatric surgery candidates)
- Individuals in safety-sensitive occupations
- Pregnant and postmenopausal women
The burden of untreated OSA extends beyond the individual patient to create substantial social and economic costs through increased healthcare utilization, work disability, and accident-related expenses 1, 8.